{"id":"W4234456851","doi":"10.2165/00128413-200716160-00066","title":"Health Canada has approved anidulafungin [Eraxis; Pfizer].","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Anidulafungin; Pharmacy; Family medicine; Dermatology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006220393,0.0004425727,0.0007510286,0.0008677937,0.001405764,0.0009534677,0.000898711,0.002292171,0.05001401],"category_scores_gemma":[0.001596028,0.0001929023,0.0007053441,0.0006832428,0.000582456,0.0003185457,0.0003805687,0.00209647,0.007967628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003018645,"about_ca_system_score_gemma":0.01185167,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1629806,"about_ca_topic_score_gemma":0.3956313,"domain_scores_codex":[0.9991143,0.0001125427,0.000032489,0.00006757843,0.0004983218,0.0001747318],"domain_scores_gemma":[0.9988394,0.0001863458,0.0000840722,0.00003428197,0.0004633953,0.0003924374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002208948,0.0008474513,0.004496961,0.0008333434,0.00009480966,0.001525948,0.00006319391,0.0003085615,0.01361723,0.003325192,0.5512203,0.421458],"study_design_scores_gemma":[0.001011968,0.0009990117,0.00773143,0.0003054504,0.0001255156,0.002370515,0.0001040043,0.0008494778,0.005849656,0.0006737245,0.9799415,0.00003778853],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0538911,0.1394107,0.007112151,0.1191102,0.01124473,0.001886902,0.0134498,0.003848802,0.6500456],"genre_scores_gemma":[0.3290341,0.06756892,0.01519294,0.03910198,0.002439357,0.0003711759,0.01089465,0.0003758403,0.5350209],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.8370194,"threshold_uncertainty_score":0.3240639,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02427527801991496,"score_gpt":0.3019655304416766,"score_spread":0.2776902524217617,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}